PAREXEL International Corporation (PRXL) has 3,800,384 shares of shorts outstanding as on August 15, 2016, with 11 days left to cover or roll them over. On Jul 29, 2016, the open interest of short positions was 3,943,570 shares. The stock has a decent trading volume of 357,368 shares daily. The marginal decrease in the short positions is by -3.6%, which amounts to -143,186 shares. Short positions are 7.3% of the available float. The short interest information was released on Wednesday Aug 24th after the market close.
PAREXEL International Corporation (NASDAQ:PRXL): The stock opened at $69.64 on Wednesday but the bulls could not build on the opening and the stock topped out at $69.98 for the day. The stock traded down to $68.02 during the day, due to lack of any buying support eventually closed down at $68.13 with a loss of -2.14% for the day. The stock had closed at $69.62 on the previous day. The total traded volume was 268,666 shares.
In a related news, Saarony Gadi, officer (Senior Vice President, CRS) of Parexel International Corp, unloaded 2,500 shares at an average price of $70.05 on August 15, 2016. The total amount of the transaction was worth $175,125, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company, which provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services to the pharmaceutical, biotechnology and medical device industries across the world. The Company operates through three segments: Clinical Research Services, PAREXEL Consulting Services and PAREXEL Informatics. Its product and service offerings include clinical trials management, data management, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, medical imaging services, electronic data capture systems, clinical trial management systems, Web-based portals, and other product development tools and services.